Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonodelestat in Cystic Fibrosis
NCT03748199Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Nov 2018
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lonodelestat in cystic fibrosis (CF), sponsored by Santhera Pharmaceuticals. Started Nov 2018; status: completed.
02
Drugs
Lonodelestat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03748199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748199.